Immutep Limited (IMM.AX)

AUD 0.23

(-6.12%)

EBITDA Summary of Immutep Limited

  • Immutep Limited's latest annual EBITDA in 2022 was -42.87 Million AUD , down -34.51% from previous year.
  • Immutep Limited's latest quarterly EBITDA in 2022 FY was N/A , down -34.51% from previous quarter.
  • Immutep Limited reported an annual EBITDA of -31.87 Million AUD in 2021, down -53.81% from previous year.
  • Immutep Limited reported an annual EBITDA of -20.72 Million AUD in 2020, down -48.66% from previous year.
  • Immutep Limited reported a quarterly EBITDA of -20.9 Million AUD for 2022 Q4, down 0.0% from previous quarter.
  • Immutep Limited reported a quarterly EBITDA of N/A for 2022 FY, down -34.51% from previous quarter.

Annual EBITDA Chart of Immutep Limited (2022 - 2007)

Historical Annual EBITDA of Immutep Limited (2022 - 2007)

Year EBITDA EBITDA Growth
2022 -42.87 Million AUD -34.51%
2021 -31.87 Million AUD -53.81%
2020 -20.72 Million AUD -48.66%
2019 -13.93 Million AUD 24.81%
2018 -18.53 Million AUD -76.37%
2017 -10.51 Million AUD -25.08%
2016 -8.4 Million AUD 86.14%
2015 -60.63 Million AUD -362.09%
2014 -13.12 Million AUD 8.95%
2013 -14.4 Million AUD 22.49%
2012 -18.59 Million AUD -2.86%
2011 -18.07 Million AUD -28.5%
2010 -14.06 Million AUD -79.97%
2009 -7.81 Million AUD -348.38%
2008 -1.74 Million AUD 6.83%
2007 -1.87 Million AUD 0.0%

Peer EBITDA Comparison of Immutep Limited

Name EBITDA EBITDA Difference
AdAlta Limited -5.3 Million AUD -708.554%
Acrux Limited -7.93 Million AUD -440.603%
Botanix Pharmaceuticals Limited -13.91 Million AUD -208.025%
BTC Health Limited 1.05 Million AUD 4162.896%
Chimeric Therapeutics Limited -11.29 Million AUD -279.434%
Clarity Pharmaceuticals Ltd -44.64 Million AUD 3.97%
Clinuvel Pharmaceuticals Limited 51.86 Million AUD 182.67%
Biome Australia Limited -1.57 Million AUD -2616.628%
Hexima Limited -995.54 Thousand AUD -4206.716%
Memphasys Limited -3.3 Million AUD -1196.216%
Neuren Pharmaceuticals Limited 199.26 Million AUD 121.517%
Noxopharm Limited -5.94 Million AUD -621.138%
Prescient Therapeutics Limited -7.18 Million AUD -496.674%
Race Oncology Limited -14.2 Million AUD -201.866%
Radiopharm Theranostics Limited -45.37 Million AUD 5.512%
Starpharma Holdings Limited -12.57 Million AUD -240.902%
Tissue Repair Ltd -5.77 Million AUD -642.429%
Biotron Limited -5.04 Million AUD -750.689%
Alterity Therapeutics Limited -19.57 Million AUD -119.068%
CSL Limited 4.73 Billion AUD 100.906%
EZZ Life Science Holdings Limited 10.37 Million AUD 513.236%
Anatara Lifesciences Ltd -1.45 Million AUD -2843.384%
Bio-Gene Technology Limited -2.97 Million AUD -1341.189%
Zelira Therapeutics Limited -36.44 Million AUD -17.656%
Patrys Limited -3.49 Million AUD -1127.759%
Orthocell Limited -11.68 Million AUD -267.047%
Imugene Limited -147.97 Million AUD 71.026%
PYC Therapeutics Limited -38.11 Million AUD -12.482%
Proteomics International Laboratories Limited -7.88 Million AUD -443.596%
Cynata Therapeutics Limited -9.95 Million AUD -330.898%
Arovella Therapeutics Limited -8.83 Million AUD -385.389%
Nanollose Limited -1.14 Million AUD -3635.096%
Invex Therapeutics Ltd -720.44 Thousand AUD -5851.245%
NeuroScientific Biopharmaceuticals Limited -1.79 Million AUD -2286.882%
Amplia Therapeutics Limited -4.55 Million AUD -840.329%
Island Pharmaceuticals Limited -2.81 Million AUD -1421.413%
Nyrada Inc. -4.59 Million AUD -832.84%
Telix Pharmaceuticals Limited 22.96 Million AUD 286.69%
Dimerix Limited -24.95 Million AUD -71.786%
PharmAust Limited -9.45 Million AUD -353.624%
AnteoTech Limited -11.57 Million AUD -270.541%
Paradigm Biopharmaceuticals Limited -64.53 Million AUD 33.567%
Recce Pharmaceuticals Ltd -21.35 Million AUD -100.782%
Avecho Biotechnology Limited -3.24 Million AUD -1222.285%
Actinogen Medical Limited -12.92 Million AUD -231.821%
Immuron Limited -6.19 Million AUD -592.389%
Argenica Therapeutics Limited -1.89 Million AUD -2159.455%